Name Net increased
positions
Increased positions Reduced positions Return since
31 Mar ‘23
551
3 31 28 80.5%
552
3 30 27 99.6%
553
3 4 1 100%
VRCA icon
554
Verrica Pharmaceuticals
VRCA
$120M
3 15 12 89.3%
555
3 8 5 22.8%
556
3 7 4 54.3%
557
3 5 2 78.1%
558
3 5 2 42.6%
559
3 4 1 91.1%
560
3 12 9 58.5%
APRZ icon
561
TrueShares Structured Outcome April ETF
APRZ
$17.3M
3 3 0 41.8%
562
3 4 1 56.6%
563
3 3 0 37.9%
564
2 5 3 34.4%
565
2 8 6 39.6%
566
2 6 4 35.7%
567
2 4 2 17.9%
568
2 2 0 75.4%
569
2 4 2 49.2%
570
2 2 0 78.5%
571
2 4 2 89.3%
572
2 12 10 7.46%
573
2 3 1 69.6%
574
2 15 13 38.3%
575
2 8 6 17.8%